Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Chembio DPP™ Zika IgM Control Pack

An external control kit for use with DPP™ Zika IgM Assay System

Supplier:  Chembio 6210010

Catalog No. 23-999-108


Due to product restrictions, please to purchase or view availability for this product.


Includes: 1 DPP Zika Reactive Control, 1 DPP Zika Nonreactive Control, 1 Product Insert
This item is not returnable. View return policy

Description

Description

  • Contains enough to perform 25 tests
  • Includes 2 vials:  reactive control and nonreactive control
  • Ready to use reagents
  • Controls are not kit lot specific and  may be interchanged between different DPP™ Zika IgM Assay System Lots
Specifications

Specifications

-20°C
Liquid
liquid
1 DPP Zika Reactive Control, 1 DPP Zika Nonreactive Control, 1 Product Insert
2 Vials
antibodies
liquid
DPP Zika IgM assay system
Box
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

i.  The test has not been FDA cleared or approved;
ii. The test has been authorized by FDA under an EUA for use by authorized laboratories;
iii. The text has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens; 
iv. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of the Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.